Skip to main content
Premium Trial:

Request an Annual Quote

Jane Dancer, Chris Kendrick-Parker, Peter White; Moharem El Gihani

Premium
Cellzome this week announced the appointment of Jane Dancer as vice president of business development. Until recently, she had been director of business development at MedImmune. Prior to that, she was global project manager at Aventis Crop Science.
 

 
Gentel Biosciences this week appointed Chris Kendrick-Parker to its board of directors. Kendrick-Parker has held various positions at Affymetrix and Amersham Pharmacia
 

 
Cambridge Research Biochemicals this week said Peter White has joined the firm as consultant technical director. Moharem El Gihani also joined the company as business development director. Cambridge is a supplier of custom peptides and antibodies to pharmaceutical companies.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.